MEDIFAST INC (MED) — Institutional Holders, Q2 2026 (page 2)

114 institutional investment managers reported a MED position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $87.7M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 114. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

MED 13F holders ranked 101–114 of 114

Institutional investors reporting a position in MEDIFAST INC on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Caitlin John#101 · 46 sh$488.000.0%
Concord Wealth Partners#102 · 33 sh$350.00New
Paladin Partners#103 · 30 sh$318.000.0%
SJS Investment Consulting#104 · 27 sh$287.00+28.6%
NISA INVESTMENT ADVISORS#105 · 22 sh$233.00+4.8%
Fortitude Family Office#106 · 18 sh$191.00New
IFG Advisory#107 · 14 sh$149.00New
Caitong International Asset Management , Ltd#108 · 12 sh$127.00-62.5%
Glass Jacobson Investment Advisors#109 · 7 sh$75.000.0%
Principia Wealth Advisory#110 · 6 sh$64.000.0%
Clearstead Advisors#111 · 2 sh$22.00New
ROYAL BANK OF CANADA#112 · 53 sh$0.00-57.9%
Covestor Ltd#113 · 15 sh$0.00-81.9%
Glen Eagle Advisors#114 · 0 sh$0.00New

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.